Relmada Therapeutics Inc. buy me8
Start price
17.10.22
/
0%
€6.70
Target price
17.10.23
-
Performance (%)
-2.99%
End price
29.10.22
€6.50
Summary
This prediction ended on 29.10.22 with a price of €6.50. With a performance of -2.99%, the BUY prediction by me8 finished with a loss. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Relmada Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 1.665% | 1.692% | 18.093% |
| iShares Nasdaq 100 | -0.475% | 1.483% | 27.860% |
| iShares Nikkei 225® | 2.620% | 4.475% | 17.651% |
| iShares S&P 500 | -0.091% | 1.099% | 24.873% |
According to me8 what are the pros and cons of Relmada Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Cons
Few uniques
Comments by me8 for this prediction
In the thread Relmada Therapeutics Inc. diskutieren
Buy Relmada Therapeutics Inc.
In the thread Trading Relmada Therapeutics Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.